Cyclooxygenase 2 1195G>A polymorphism is associated with chronic obstructive pulmonary disease in Japanese and Chinese patients

Author:

CHEN Li-jun,XU Wang,Yasuyuki Taooka,Miki Ohe,Hitoshi Takahashi,Akihisa Sutani,Takashige Kuraki,Takeshi Isobe

Abstract

Background Cyclooxygenase-2 (COX-2) is overexpressed during airway inflammation in chronic obstructive pulmonary disease (COPD) patients. Single nucleotide polymorphisms (SNPs) in the COX-2 promoter might contribute to differential COX-2 expression and subsequent interindividual variability in susceptibility to COPD. We investigated the association between COX-2 (-765G>C, -1195G>A) polymorphisms and COPD susceptibility in Japanese and Chinese patients. Methods COX-2 genotypes were determined by polymerase chain reaction, restriction fragment length polymorphism in 230 COPD patients (103 Japanese and 127 Chinese) and 273 healthy controls (129 Japanese and 144 Chinese). Results The frequency of -1195AA homozygote was significantly higher than the controls in Chinese COPD (adjusted OR=2.43, 95% CI 1.14-4.19), Japanese COPD (adjusted OR=2.25, 95% CI 1.06-4.76) and combined COPD groups (adjusted OR=2.26, 95% CI 1.34-3.99). There was no difference in COX-2-765G>C polymorphism between COPD and control groups in either Japanese or Chinese, while more Chinese individuals carried the -765C allele than Japanese in both groups (15.3% vs. 2.9% in COPD, 18.8% vs. 5.5% in control). Chinese individuals with the haplotype -765G:-1195A were at higher risk for COPD (adjusted OR=1.93, 95% CI 1.05-3.55). Conclusions The COX-2-1195AA genotype is associated with increased risk for COPD in both Japanese and Chinese individuals. Although COX-2-765G>C polymorphism was not associated with COPD in either ethnic group, the -765C allele frequency was higher in Chinese than Japanese and haplotype -765G-1195A may confer susceptibility to COPD in Chinese.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3